Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 2;28(5):2325.
doi: 10.3390/molecules28052325.

Multifunctional Fe3O4 Nanoparticles Filled Polydopamine Hollow Rods for Antibacterial Biofilm Treatment

Affiliations

Multifunctional Fe3O4 Nanoparticles Filled Polydopamine Hollow Rods for Antibacterial Biofilm Treatment

Huy Quang Tran et al. Molecules. .

Abstract

This work reports the use of mesoporous silica rods as templates for the step-wise preparation of multifunctional Fe3O4 NPs filled polydopamine hollow rods (Fe3O4@PDA HR). The capacity of as-synthesized Fe3O4@PDA HR as a new drug carrier platform was assessed by its loading and the triggered release of fosfomycin under various stimulations. It was found that the release of fosfomycin was pH dependent with ~89% of fosfomycin being released in pH 5 after 24 h, which was 2-fold higher than that in pH 7. The magnetic properties of Fe3O4 NPs and the photothermal properties of PDA enabled the triggered release of fosfomycin upon the exposure to rotational magnetic field, or NIR laser irradiation. Additionally, the capability of using multifunctional Fe3O4@PDA HR to eliminate preformed bacterial biofilm was demonstrated. Upon exposure to the rotational magnetic field, the biomass of a preformed biofilm was significantly reduced by 65.3% after a 20 min treatment with Fe3O4@PDA HR. Again, due to the excellent photothermal properties of PDA, a dramatic biomass decline (72.5%) was achieved after 10 min of laser exposure. This study offers an alternative approach of using drug carrier platform as a physical mean to kill pathogenic bacteria along with its traditional use for drug delivery.

Keywords: Fe3O4 nanoparticles; drug delivery system; fosfomycin; polydopamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration for the preparation of Fe3O4 NPs filled PDA HR.
Figure 2
Figure 2
SEM image of synthesized MSR and its size distribution (A) and TEM image of monodisperse Fe3O4 NPs and its size distribution (B).
Figure 3
Figure 3
XRD pattern of monodisperse Fe3O4 NPs, MSR-COOH and Fe3O4 grafted MSR.
Figure 4
Figure 4
SEM (A), TEM (B) images and EDX analysis (C) of Fe3O4 filled PDA HR.
Figure 5
Figure 5
Release profile of fosfomycin from Fe3O4@PDA HR at different pH and upon the exposure to a rotational magnetic field (A) and upon NIR laser irradiation (B).
Figure 6
Figure 6
Inhibitory effect on biofilm formation of fosfomycin loaded Fe3O4@PDA HR and free fosfomycin drug molecules.
Figure 7
Figure 7
Reduction of pre-formed biofilm biomass upon exposure to rotational magnetic field (A), and SEM images of pre-formed biofilm upon exposure to rotational magnetic field (B): biofilm only (i), biofilm with added Fe3O4 NPs (ii) and biofilm with added Fe3O4@PDA HR (iii).
Figure 8
Figure 8
Live/dead cell staining of S. aureus biofilms under different treatment: control preformed biofilm (A), preformed biofilm treated with bare Fe3O4 NPs (B) and preformed biofilm treated with Fe3O4 @PDA HR (C) under rotational magnetic field (Scale bar = 10 µm).
Figure 9
Figure 9
Photothermal conversion performance of bare Fe3O4 and Fe3O4@PDA HR (A) and photostability of Fe3O4@PDA HR (B); Reduction of preformed biofilm biomass upon laser irradiation (C) and live/dead cell staining of biofilm treated with Fe3O4@PDA HR upon exposure to NIR laser (Scale bar = 10 µm) (D).

Similar articles

Cited by

References

    1. Manzano M., Vallet-Regí M. Mesoporous silica nanoparticles for drug delivery. Adv. Funct. Mater. 2020;30:1902634. doi: 10.1002/adfm.201902634. - DOI
    1. García-Fernández A., Aznar E., Martínez-Máñez R., Sancenón F. New advances in in vivo applications of gated mesoporous silica as drug delivery nanocarriers. Small. 2020;16:1902242. doi: 10.1002/smll.201902242. - DOI - PubMed
    1. Li Z., Zhang Y., Feng N. Mesoporous silica nanoparticles: Synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin. Drug Deliv. 2019;16:219–237. doi: 10.1080/17425247.2019.1575806. - DOI - PubMed
    1. Liu X., Appelhans D., Voit B. Hollow capsules with multiresponsive valves for controlled enzymatic reactions. J. Am. Chem. Soc. 2018;140:16106–16114. doi: 10.1021/jacs.8b07980. - DOI - PubMed
    1. Guo X., González K.S., Lynn D.M. Templated synthesis of polymer-based yolk/shell particles with tunable morphologies. Chem. Mater. 2019;31:7443–7452. doi: 10.1021/acs.chemmater.9b02107. - DOI

LinkOut - more resources